- Urologic Oncology
- Genomic Testing
- Biomarkers
- Non-Muscle Invasive Bladder Cancer (NMIBC)
- Muscle Invasive Bladder Cancer (MIBC)
- Bladder Cancer
Can genomic classifiers close the gap between what we see and what a tumor will do? In this episode of BackTable Urology, Dr. Carissa Chu (UCSF) joins Dr. Ruchika Talwar (Vanderbilt) to explore how genomic classifiers are reshaping the way clinicians diagnose and manage bladder cancer.
This podcast is supported by